期刊文献+

全球消灭脊髓灰质炎最后阶段我国脊髓灰质炎疫苗免疫策略的探讨 被引量:7

The discussion of inactivated poliovirus vaccine immunization strategy in China during the global polio eradication stage
原文传递
导出
摘要 脊髓灰质炎(脊灰)是严重危害人类健康的一种传染性疾病,也是世界卫生组织(WHO)继天花之后要根除的第二种传染病。自1988年世界卫生大会(WHA)确定了在2000年消灭脊灰的目标以来,全球脊灰病例已经下降了99%。脊灰病例数从1988年的约35万例下降到2013年的406例,脊灰野病毒本土流行的国家也从125个减少到3个,这是全球共同努力的结果。 Since its launching at the World Health Assembly (WHA) in 1988, the Global Polio Eradication Initiative (GPEI) has reduced the global incidence of polio by over 99%, from an estimated 350 000 cases then to 406 reported cases in 2013, and the number of countries with endemic polio from 125 to 3. The reduction is the result of the global effort to eradicate the disease. In 2012, the World Health Assembly declared ending po- lio a "programmatic emergency for global public health" and developed the Polio Eradication ~ Endgame Stra- tegic Plan 2013-2018. In the plan, all countries are recommended to introduce at least 1 dose of IPV into their routine immunization programs to reduce the consequences of a subsequent circulating poliovirus after OPV2 cessation. Under certain conditions, how should at least one dose of IPV be introduced into Chinese routine im- munization programs, what problems might be met during the process and what lessons we could learn from a- broad are of great interest to us. During the meeting, experts shared the experiences of introducing IPV into their routine immunization programs and provided suggestions to us. Proper communication strategy and main- taining the high coverage of vaccination are the primary factors during the vaccine policy changing period.
机构地区 中华预防医学会
出处 《中国病毒病杂志》 CAS 2015年第3期167-170,共4页 Chinese Journal of Viral Diseases
关键词 脊髓灰质炎 灭活脊髓灰质炎疫苗(IPV) 口服脊髓灰质炎减毒活疫苗(OPV) 免疫策略 Poliomyelitis Inactivated poliovirus vaccine (IPV) Attenuated oral poliovirus vaccine (OPV)~ Immunization strategy
  • 相关文献

参考文献11

  • 1WHO. Poliomyelitis fact sheet, Oct 2014 [EB/OL]. [2015- 03-02]. http: //www. who. int/mediacentre/factsheets/fs114/ zh/.
  • 2WHO. Polio vaccines: WHO position paper, January 2014 [J]. Wkly Epidemiol Ree, 2014, 89 (9): 73-92.
  • 3WHO. Circulating vaccine-derived poliov~rus (eVDPV) 2000- 2015 [EB/OL]. [2015-03-02]. http: //www. polioeradica tion. org/Dataandmonitorirtg/Poliothisweek/Circulatingvaceine- derivedpo!.iovirus, aspx-.
  • 4Vidor E, Meschievitz C, Plotkin S. Fifteen years of experi ence with Vero-produced enhanced potency inactivated poliovirus vaccine [J]. Pediatric Infect Dis J, 1997, 16 (3) : 312 322.
  • 5Alexander LN, Seward JF, Santibanez TA, et al. Vaccine policy changes and epidemiology of poliomyelitis in the U- nited States [J]. JAMA, 2004, 292 (14): 1696-1701.
  • 6Centers for Disease Control and Prevention. Poliomyelitis prevention in the United States: introduction of a sequen- tial vaccination schedule of inactivated poliovirus vaccine fol lowed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP) [J]. MMWR Recomm Rep, 1997, 46 (RR-3): 1-25.
  • 7Hosoda M, Inoue H, Miyazawa Y, et al. Vaccine-associated paralytic poliomyelitis in Japan [J]. Lancet, 2012, 379 (9815): 520.
  • 8Tomisaka M, Makino T, Marui E. Overcoming the Japanese "Vaccine Gap": an analysis of medical leaders' witness [J]. J Vaccines Vaccin, 2015, 6: 253.
  • 9Domingues CM, de F6tima Pereira S, Cunha Marreiros AC, et al. Introduction of sequential inactivated polio vaccine- oral polio vaccine schedule for routine infant immunization in Brazil's National Immunization Program [J]. J Infect Dis, 2014, 210 Suppll: S143-$151.
  • 10John TJ. The golden jubilee of vaccination against poliomye- litis [J]. Indian J Med Res, 2004, 119 (1) : 1-17.

同被引文献43

引证文献7

二级引证文献85

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部